Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling.

Spangler JB, Neil JR, Abramovitch S, Yarden Y, White FM, Lauffenburger DA, Wittrup KD.

Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13252-7. doi: 10.1073/pnas.0913476107. Epub 2010 Jul 7.

3.

Down-regulation of epidermal growth factor receptor signalling within multivesicular bodies.

Eden ER, White IJ, Futter CE.

Biochem Soc Trans. 2009 Feb;37(Pt 1):173-7. doi: 10.1042/BST0370173. Review.

PMID:
19143625
4.

Clinical experience with monoclonal antibodies to epidermal growth factor receptor.

Calvo E, Rowinsky EK.

Curr Oncol Rep. 2005 Mar;7(2):96-103. Review.

PMID:
15717942
5.

Epidermal growth factor receptor as a therapeutic target in glioblastoma.

Kalman B, Szep E, Garzuly F, Post DE.

Neuromolecular Med. 2013 Jun;15(2):420-34. doi: 10.1007/s12017-013-8229-y. Epub 2013 Apr 11. Review.

PMID:
23575987
6.

Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers.

Simon N, FitzGerald D.

Toxins (Basel). 2016 May 4;8(5). pii: E137. doi: 10.3390/toxins8050137. Review.

Supplemental Content

Support Center